Hip Fractures: Clinical Trials

22 trials for Hip Fractures, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

22 completed. 22 Phase 2, 3 Phase 3, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 222Completed 22
Phase 33Completed 3
Phase 11Completed 1

Follow Hip Fractures: new trials by email Literature Review of Hip Fractures trials Research Report on Hip Fractures

Trials (filtered) newest first · largest first

All 22 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Abaloparatide and Pelvic Fracture Healing
Abaloparatide 80 micrograms per Pen dose, Placebo prefilled injector pen - Fracture of Pelvis (Disorder)
Phase 2CompletedHospital for Special Surgery, New York482020-09-172024-06-14
Physiotherapy, Nutritional Supplement and Anabolic Steroids in Rehabilitation of Patients With Hip Fracture.
Nandrolone Decanoate, Protein-rich nutritional supplement, Physical therapy - Hip Fractures
Phase 2CompletedMorten Tange Kristensen PT, PhD292018-09-032021-02-12
Does Early Administration of Tranexamic Acid Reduce Blood Loss and Perioperative Transfusion Requirement
Tranexamic Acid (TXA), Placebo - Hip Fractures, Intertrochanteric Fractures
Phase 2CompletedMayo Clinic1282018-04-022023-03-30
PTH(1-34) and Pelvic Fracture Healing - a Randomized Controlled Trial
Teriparatide Prefilled Syringe, Placebo - Osteoporotic Fractures
Phase 2CompletedHospital for Special Surgery, New York352017-05-012022-07-27
Shamrock - Ultrasound/MR Image Fusion Guided Lumbar Plexus Block
Ultrasound/MR image fusion guided lumbar plexus block (Shamrock), Ultrasound guided lumbar plexus block (Shamrock), Lidocaine-epinephrine added gadoterate meglumine - Hip Fractures, Anesthesia, Local
Phase 2CompletedUniversity of Aarhus222016-03-012016-04-26
Acute Hip Fracture Study in Patients 65 Years or Greater
VK5211, Placebo - Hip Fractures
Phase 2CompletedViking Therapeutics, Inc.1082015-10-302025-12-29
Study of Efficacy and Safety of Bimagrumab in Patients After Hip Fracture Surgery
bimagrumab, placebo - Muscle Wasting (Atrophy) After Hip Fracture Surgery
Phase 2CompletedNovartis Pharmaceuticals2512014-09-162020-08-19
Pilot Study of Atorvastatin for Orthopedic Surgery Patients
Atorvastatin, Placebo - Hip Fracture, Myocardial Ischemia
Phase 2CompletedHospital for Special Surgery, New York202014-09-012017-07-02
Navigator vs Standard Needle Injection for Hip
Celestone, Lidocaine - Hip Pain Etiology Unknown
Phase 2CompletedCartiva, Inc.402014-02-012016-01-28
Study of Low-Magnitude, High-Frequency Vibration Treatment on Osteoporotic Hip Fracture Healing
Low-magnitude high - frequency vibration treatment - Hip Fracture
Phase 2 / Phase 3CompletedChinese University of Hong Kong722011-11-012012-05-23
Training of Patients With Hip Fracture
Strength training - Hip Fracture
Phase 2CompletedLolland Community, Denmark1002010-09-012014-08-07
Hip Fracture Surgery in Elderly Patients
Xenon, Sevoflurane - Delirium
Phase 2CompletedAir Liquide Santé International2562010-09-012015-07-27
Study To Assess FRacTure Healing With SclerosTin Antibody - Hip
Placebo, Romosozumab - Fracture Healing
Phase 2CompletedAmgen3322010-06-202022-09-21
An Inpatient Rehabilitation Model of Care Targeting Patients With Cognitive Impairment
Rehabilitation Model of Care - Hip Fracture
Phase 2 / Phase 3CompletedUniversity Health Network, Toronto1982009-08-012014-04-24
Enhanced Medical Rehabilitation for Disablement
Enhanced acute medical rehabilitation, Treatment as usual - Hip Fracture, Depression
Phase 2CompletedWashington University School of Medicine252009-08-012014-03-19
Ultrasound-guided Femoral Nerve Blocks in Elderly Patients With Hip Fractures
Femoral nerve block: 25 mL of 0.5% bupivacaine, Placebo: 3cc of 0.9% Normal Saline - Femoral Neck Fractures, Hip Fractures
Phase 2CompletedRhode Island Hospital382008-11-012014-03-12
Supporting the Health of Adults Undergoing Orthopedic Surgery During the Recovery Period
donepezil, Placebo - Delirium
Phase 2CompletedBeth Israel Deaconess Medical Center162007-01-012014-08-22
Effectiveness of Two Types of Treatment in Restoring Muscle After Hip or Knee Surgery
Essential amino acid supplement, Ketoconazole, Placebo - Hip Fracture, Osteoarthritis
Phase 2CompletedUniversity of Arkansas402006-10-012014-06-02
Factor IX Inhibition in Thrombosis Prevention (The FIXIT Trial)
TTP889 - Venous Thromboembolism, Embolism and Thrombosis
Phase 2CompletedvTv Therapeutics3002005-01-012009-06-03
Secondary Prevention of Osteoporotic Fractures in Residents of Long-Term Care Facilities
Long-term care facilities in the intervention arm will receive education and feedback audit on performance - Hip Fractures, Osteoporosis
Phase 2 / Phase 3CompletedDuke University642005-01-012023-10-26

Showing 20 of 22. Sign in to see all of them.

Narrower conditions

Delirium (2)  ·  Atrophy (1)  ·  Cognitive Dysfunction (1)  ·  Depression (1)  ·  Embolism (1)  ·  Embolism and Thrombosis (1)  ·  Femoral Neck Fractures (1)  ·  Femur Head Necrosis (1)  ·  Fractures, Bone (1)  ·  Inflammation (1)  ·  Motor Activity (1)  ·  Muscle Weakness (1)  ·  Muscular Atrophy (1)  ·  Myocardial Ischemia (1)

Broader conditions

Femoral Fractures (22)  ·  Hip Injuries (22)  ·  Leg Injuries (22)  ·  Wounds and Injuries (22)  ·  Fractures, Bone (21)  ·  Pathological Conditions, Signs and Symptoms (7)  ·  Neurologic Manifestations (5)  ·  Signs and Symptoms (5)  ·  Nervous System Diseases (4)  ·  Pathologic Processes (4)  ·  Mental Disorders (3)  ·  Musculoskeletal Diseases (3)  ·  Neurocognitive Disorders (3)  ·  Behavior (2)  ·  Bone Diseases (2)

Interventions

Anabolic Androgenic Steroids (1)  ·  Atorvastatin (1)  ·  Betamethasone (1)  ·  Bupivacaine (1)  ·  Donepezil (1)  ·  Home Nursing (1)  ·  Ketoconazole (1)  ·  Lidocaine (1)  ·  Nandrolone (1)  ·  Nandrolone Decanoate (1)  ·  Physical Therapy Modalities (1)  ·  Resistance Training (1)  ·  Saline Solution (1)  ·  Sevoflurane (1)  ·  Sodium Chloride (1)

Sponsors

Hospital for Special Surgery, New York (3)  ·  Washington University School of Medicine (2)  ·  Air Liquide Santé International (1)  ·  Amgen (1)  ·  Arcadia University (1)  ·  Beth Israel Deaconess Medical Center (1)  ·  Cartiva, Inc. (1)  ·  Chinese University of Hong Kong (1)  ·  Duke University (1)  ·  Lolland Community, Denmark (1)  ·  Mayo Clinic (1)  ·  Morten Tange Kristensen PT, PhD (1)  ·  Novartis Pharmaceuticals (1)  ·  Rhode Island Hospital (1)  ·  University Health Network, Toronto (1)

Countries

United States (15)  ·  Denmark (4)  ·  Belgium (3)  ·  Germany (3)  ·  Hungary (3)  ·  United Kingdom (3)  ·  Argentina (2)  ·  Australia (2)  ·  Canada (2)  ·  Czechia (2)  ·  France (2)  ·  Italy (2)  ·  Spain (2)  ·  Sweden (2)  ·  Switzerland (2)

Top investigators

Jeri W Nieves, PhD (2)  ·  Anne R Bass, MD (1)  ·  Arny Ferrando, PhD (1)  ·  Bengt I Eriksson, MD (1)  ·  Brandon Yuan, MD (1)  ·  Brian Giordano, MD (1)  ·  Cathleen S. Colon-Emeric, MD, MHSc (1)  ·  David P Ward, MD (1)  ·  Edward R Marcantonio, MD (1)  ·  Ellen F. Binder, MD (1)  ·  Eric J Lenze, MD (1)  ·  Francesca Beaudoin, MD, MS (1)  ·  Jan Overgaard, MSc. (1)  ·  Jennie MC Strid, M.D. (1)  ·  Joseph Lane, MD (1)

Results publications

PMID 17904460, PMID 18088349, PMID 22091574, PMID 22631877, PMID 22863663, PMID 23016882, PMID 24330470, PMID 29397119, PMID 29398998, PMID 31870451, PMID 33238043, PMID 34016037, PMID 34383100, PMID 34460897, PMID 34766330, PMID 36070134, PMID 36098133, PMID 42618812

NIH funding

2017 (1), R01AR052293 (1), R03HD041944 (1), R21AG027549 (1), UL1TR000457-06 (1)